Access to innovative medicines
This discussion took place in January 2016 between Mark Chataway, Ajoy Bose and Nikhil Murali to discuss access to innovative medicines in India with particular focus on the public and private sector, generics, the threat of compulsory licencing and biosimilars.
The presentation
The presentation was created in Prezi, you can move forwards and backwards using the left and right arrows at the bottom of the presentation.
The Three Commitments
Why Consultants end up not telling the truth
The worst kind of market research interviewing technique ever
Why bright people can’t explain themselves
